Regulation of catalytic activity of S6 kinase 2 during cell cycle

被引:23
作者
Boyer, Derek [1 ]
Quintanilla, Rene [1 ]
Lee-Fruman, Kay K. [1 ]
机构
[1] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA
关键词
Ribosomal S6 kinase 1 (S6K1); Ribosomal S6 kinase 2 (S6K2);
D O I
10.1007/s11010-007-9584-5
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ribosomal S6 kinase 2 (S6K2) is one of the kinases regulated by the mammalian target of rapamycin (mTOR) signaling pathway. Although it has been identified as a kinase homologous to S6K1, evidence suggests that the two kinases have non-overlapping functions, and the biological function of S6K2 still remains unknown. In order to identify the cell cycle stage(s) during which S6K2 plays a role, we assessed changes in the catalytic activity of S6K2 throughout the cell cycle. Our data show that S6K2 is active throughout the cell cycle with higher activity in G2 and M phases. We also show that S6K1 activity peaks sharply during M phase. Our data suggest that S6K1 and S6K2 likely play yet-unknown roles in G2 and M phases.
引用
收藏
页码:59 / 64
页数:6
相关论文
共 16 条
[1]  
Avruch J, 2001, Prog Mol Subcell Biol, V26, P115
[2]   Cell cycle regulation of p70 S6 kinase and p42/p44 mitogen-activated protein kinases in Swiss mouse 3T3 fibroblasts [J].
Edelmann, HML ;
Kuhne, C ;
Petritsch, C ;
Ballou, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :963-971
[3]   Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression [J].
Fingar, DC ;
Blenis, J .
ONCOGENE, 2004, 23 (18) :3151-3171
[4]   Molecular cloning and characterization of a novel p70 S6 kinase, p70 S6 kinase β containing a proline-rich region [J].
Gout, I ;
Minami, T ;
Hara, K ;
Tsujishita, Y ;
Filonenko, V ;
Waterfield, MD ;
Yonezawa, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (46) :30061-30064
[5]   Cloning and characterization of a nuclear S6 kinase, S6 kinase-related kinase (SRK); A novel nuclear target of Akt [J].
Koh, H ;
Jee, K ;
Lee, B ;
Kim, J ;
Kim, D ;
Yun, YH ;
Kim, JW ;
Choi, HS ;
Chung, J .
ONCOGENE, 1999, 18 (36) :5115-5119
[6]   Characterization of S6K2, a novel kinase homologous to S6K1 [J].
Lee-Fruman, KK ;
Kuo, CJ ;
Lippincott, J ;
Terada, N ;
Blenis, J .
ONCOGENE, 1999, 18 (36) :5108-5114
[7]   MTOR, translation initiation and cancer [J].
Mamane, Y. ;
Petroulakis, E. ;
LeBacquer, O. ;
Sonenberg, N. .
ONCOGENE, 2006, 25 (48) :6416-6422
[8]   Atrophy of S6K1-/- skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control [J].
Ohanna, M ;
Sobering, AK ;
Lapointe, T ;
Lorenzo, L ;
Praud, C ;
Petroulakis, E ;
Sonenberg, N ;
Kelly, PA ;
Sotiropoulos, A ;
Pende, M .
NATURE CELL BIOLOGY, 2005, 7 (03) :286-294
[9]   S6K1-/-/S6K2-/- mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway [J].
Pende, M ;
Um, SH ;
Mieulet, V ;
Sticker, M ;
Goss, VL ;
Mestan, J ;
Mueller, M ;
Fumagalli, S ;
Kozma, SC ;
Thomas, G .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (08) :3112-3124
[10]   Mutational analysis of ribosomal S6 kinase 2 shows differential regulation of its kinase activity from that of ribosomal S6 kinase 1 [J].
Phin, S ;
Kupferwasser, D ;
Lam, J ;
Lee-Fruman, KK .
BIOCHEMICAL JOURNAL, 2003, 373 (02) :583-591